Patient leaflet - Flumazenil Kabi 0.1 mg / ml solution for injection., Fresenius Flumazenil 0.1 mg / ml solution for injection
1. What Flumazenil is an
Flumazenil is a counterage or partial reversal of the ce benzodiazepines (specific gr muscle relaxing and anxiolyt It may therefore be used in after certain diagnostic tes been held under sedative c be used for the diagnosis a overdose with benzodiazep
Flumazenil is also used in c old) to wake them up after ‘benzodiazepine’ medicine medical procedure.
2. What you need to kno
Do not use Flumazenil
if you are allergic (hy
of the other ingredien
if benzodiazepines ha
control a potentially example control of pr
and other information
d what it is used for
nt (antidote) for the complete ntral sedative effects of
oup with sedative, sleep inducing, ic properties).
anaesthesia to wake you up ts or in intensive care if you have onditions. Flumazenil may also nd treatment of intoxications or ines.
hildren (more than 1 year they have been given a
to make them sleepy during a
w before you use Flumazenil
persensitive) to flumazenil or any ts (listed in section 6).
ve been administered to you to life-threatening situation (for essure in the brain or a serious
epileptic seizure).
in mixed intoxication
certain types of other tricyclic and tetracycli Clomipramine, Mirtaz of these antidepressants benzodiazepine effects. a significant overdos Flumazenil must not benzodiazepine effe
Warnings and precautio
If you do not wake u
administered, another because Flumazenil spe benzodiazepines.
If Flumazenil is admini
operation to wake y the effects of muscle
As the action of flum
of benzodiazepines, s will be closely observ unit until the effects
If you have received h
(chronic) treatment w
s with benzodiazepines and antidepressants (so called c antidepressants like Imipramine, apine or Mianserin). The toxicity can be masked by protective If you are showing signs of e of these antidepressants, be used to reverse
cts.
ns
p after Flumazenil is
reason for this will be considered cifically reverses the effects of
stered to you at the end of your ou up, it should not be given until relaxants have gone away. azenil is usually shorter than that edation may possibly recur. You ed, possibly in the intensive care of flumazenil have gone away. igh dose and/or long-term ith benzodiazepines, at any
time within the weeks prec administration, rapid inject flumazenil (more than 1 mg this may cause withdrawal
- 4. Possible side effects).
If you have been treated for
doses of benzodiazepines, of Flumazenil should be car risk of withdrawal symptom
In children previously sedate
These children should be clo care units for at least 2 ho of Flumazenil because rep difficulty with breathin
sedation by other benzodia must be adjusted according duration.
If you are epileptic and hav
treatment for a long period
eding flumazenil ion of high doses of ) should be avoided since symptoms (see section long periods with high the advantages of the use efully weighed against the s.
d with midazolam. sely observed in intensive urs after administration eated sedation or g can occur. In case of zepines, the monitoring to their expected e received benzodiazepine of time, the administration ion of flumazenil is not recomm cause seizures.
Seizures or other toxic effec
cases of mixed drug overdo benzodiazepines and cyclic
If you have serious brain in
pressure in your brain) care w can cause an increased pre
As Flumazenil is not recomm
benzodiazepine-dependen benzodiazepines-withdra
If you have experienced p
Flumazenil can cause new
If you are dependent on alc
have a higher risk of benzo dependence.
if your liver is not working
elimination can be delayed
Children
Children should only receive Fl
sedation. There are unsuffi indications. The same applie age of 1 year
Other medicines and Flumaze
Tell your doctor if you are taking other medicines, including medic prescription.
ended as flumazenil can ts can be more severe in se (e.g. intoxication with antidepressents)
jury (and/or instable illl be taken as Flumazenil ssure in your brain. ended for the treatment of ce or for the treatment of wal-symptoms.
anic attacks in the past attacks.
ohol or medicines as you diazepine tolerance and well flumazenil
.
umazenil after deliberate cient data for any other s for children below the nil
or have recently taken any ines obtained without a
When using Flumazenil in cases of has to be taken into account that t psychotropic medicinal products (e anti-depressants like Imipramine) t increase with the subsidence of the Interaction with other central ner has not been observed.
Flumazenil with alcohol
There is no known interaction betw
Pregnancy, breast-feeding and
If you are pregnant or breast-fe pregnant or are planning to hav or pharmacist for advice before
Because of insufficient experien Flumazenil should only be used is higher than the potential risk The administration of Flumazen contraindicated in an emergenc
It is not known whether flumaze milk. Therefore it is recommend hours after administration of Flu
an accidental overdose it he toxic effects of other specially tricyclic aken concurrently, may benzodiazepine effect. vous system depressants een ethanol and flumazenil.
fertility eding, think you may be e a baby, ask your doctor taking this medicine.
ce during pregnanacy if the advantage for you for the unborn baby. il during pregnancy is not y situation.
nil is excreted in breast ed not to breast-feed 24 mazenil
Driving and using machi
After receiving Flumazenil effects of benzodiazepines machinery or engage in a demanding activity for at possibly recur.
Flumazenil contains sod
This medicinal product con mg / 5 ml ampoule size or solution for injection. To b patients on a controlled so
3. How to use Flumazen
Flumazenil is administered a vein) or diluted as intrave period).
Flumazenil will be given by physician. Flumazenil may resuscitative measures. This medicinal product is f solution should be discarde inspected visually prior to u solution is clear, colourless
nes
for the reversal of the sedative you must not drive a car, operate ny other physically or mentally least 24 hours since sedation may
ium chloride
tains 3.7 mg sodium per ml (18.5 37 mg / 10 ml ampoule size) e taken into consideration by dium diet.
il
as intravenous injection (into nous infusion (over a longer
your anaesthetist or experienced be used at the same time as other
or single use only. Any unused d. The solution should be se. It should only be used if the and practically free from particles.
The recommended dose is
Anaesthesia
Dos
Starting dose:
0.2 mg administered intravenously over a perio of 15 seconds.
A further dose of 0.1 mg can be injected and
repeated at 60 second intervals, if required level of consciousness is not obtain within 60 seconds, up to a maximum dose of 1.0 mg. The usual dose required lies between 0.3 and 0.6 mg, but may deviate depending on the patient characteristics and the benzodiazepine used.
described as follows:
Adults
Intensive Care
age level:
d
Starting dose:
0.3 mg administered intravenously over a period of 15 seconds.
ed
A further dose of 0.1 mg can be injected and repeated at 60 second intervals, if required level of consciousness is not obtained within 60 seconds, up to a maximum dose of 2.0 mg.
s
If drowsiness recurs a second bolus injection may be
administered. An intravenous infusion of 0.1- 0.4 mg/h has also been shown useful. The dosage and rate of infusion should be adjusted individually to achieve the desired level of consciousness
The infusion can be given additionally to the maximum
dose of 2 mg by injection.
Patients with renal (kidney) or impairment
In patients with impaired liver fun flumazenil may be delayed and t of dosage is recommended.
No dosage adjustments are req impaired kidney function.
Use in Children
Children above 1
Reversal of delibe
Dosage le
The recommended initial dose to 200 micrograms), administe seconds. If the desired level of co after waiting an additional 45 of 10 micrograms//kg may be micrograms) and repeated at 6 necessary (a maximum of 4 time of 50 micrograms/kg or 1 mg, w
Children under the age of 1 ye
hepatic (liver)
ction, the elimination of herefore careful titration uired in patients with year of age rate sedation vel:
is 10 micrograms/kg (up red intravenously over 15 nsciousness is not obtained seconds, further injection administered (up to 200 0 second intervals where
- s) to a maximum total dose hichever is lower.
ar
There are insufficient data on the children under 1 year. Therefore F be administered in children unde benefits to the patient outweigh
If you have any further questions ask your doctor or pharmacist. For information intended for heal see accordant section below.
4. Possible side effects
Like all medicines, this medicine c although not everybody gets the
Very common (may affect mor
Nausea
Common (may affect up to 1 i
hypersensitivity reactions (allergic (after rapid injection, not requirin lability, having problems in initiati (insomnia), feeling sleepy (somno agitation (after rapid injection, no unvoluntary trembling or quiverin abnormal rapid and deep respirat speech disorder, subjective cutan cold, warmth, tingling, pressure,
use of Flumazenil in lumazenil should only r 1 year if the potential the possible risk.
on the use of this product, thcare professionals please an cause side effects, m.
e than 1 in 10 people)
n 10 people)
reactions), anxiety g treatment), emotional ng and maintaining sleep lence), vertigo, headache, t requiring treatment), g (tremor), dry mouth, ion (hyperventilation), eous sensations (e.g. etc.) in the absence of stimulation (paresthesia), doub (squinting), lacrimation (producti heart palpitations (after rapid inje treatment), reddening of the skin pressure on transition from lying increased blood pressure (on awa sweating, fatigue, injection site p
le vision, strabismus on of tear fluid) increased, ction, not requiring (flushing), low blood to standing, transient king), vomitting, hiccup, ain
mazenil 0.1 mg/ml
Solution for Inject
PACKAGE LEAFLET: INFO
RMATION FOR THE USER
| Product Name: Flumazenil | Territory: UK |
|
| Variable Data: | ||
| Type of Packaging: Leaflet | Dosage: - | |||||
| Material number: M0xxxxx/xx UK | 2-D-Matrix Code M0xxxxx/xx UK | |||||
| Code: – | ||||||
| 180 x 588 mm | Smallest Size: Arial 8 | |||||
| Operator: Roberto Grill +43(0) 699-17181288 | ||||||
Uncommon (may affect
Fear (after rapid injection, convulsions (in patients suf liver insufficiency, mainly a benzodiazepines or mixed warnings and precautions) heart rate, premature beat difficulty breathing (dyspn chest pain, shivering (after treatment).
Not known (frequency c available data)
Withdrawal symptoms (see with a history of panic reac aggressive reactions, severe
If you were treated for a lo flumazenil can induce wit symptoms are: tension, a lability, confusion, hallucin quivering (tremor) and con
In general the undesirabl differ much from that in a
up to 1 in 100 people)
not requiring treatment),
fering from epilepsy or severe fter long-term treatment with drug overdose (see section 2 , abnormal hearing, slow or rapid of your heart (extrasystole), oea), cough, nasal congestion, rapid injection, not requiring
annot be estimated from the
below); panic attacks (in patients tions); abnormal crying, agitation, allergic reactions (anaphylaxis).
ng period with benzodiazepines hdrawal symptoms. The gitation, anxiety, emotional ations, involuntary trembling or vulsions.
e effects in children do not dults. When using Flumazenil to
awaken a child from sedat and aggressive reactions h
Reporting of side effects
If you get any side effects, any possible side effects no also report side effects dire
United Kingdom
Yellow Card Scheme Website: www.mhra.gov.u
Ireland
HPRA Pharmacovigilance Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie
By reporting side effects yo information on the safety
5. How to store Flumaze
Keep this medicine out of
ion, abnormal crying, agitation ave been reported.
talk to your doctor. This includes t listed in this leaflet. You can ctly (see details below).
k/yellowcard
u can help provide more of this medicine.
nil
the sight and reach of children.
Do not use this medicine a stated on the label and car last day of that month. Do not store above 25°C This medicinal product is f Shelf life after first openin be used immediately. Shelf life after dilution: 24 Chemical and physical in-u demonstrated for 24 hours From a microbiological poi used immediately. If not us times and conditions prior the user and would norma 2 to 8 °C, unless dilution h validated aseptic condition
Do not use this medicine if from particles.
Any unused solution shoul local requirements.
fter the expiry date which is ton. The expiry date refers to the
or single use only.
g: the medicinal product should
hours.
se stability has been
at 25°C.
nt of view, the product should be ed immediately, in-use storage to use are the responsibility of lly not be longer than 24 hours at as taken place in controlled and s.
the solution is not clear and free
d be discarded in accordance with
Do not throw away any medicines household waste. Ask your pharm medicines you no longer use. The protect the environment.
6. Contents of the pack and ot
What Flumazenil contains
The active substance is flumaze
Each millilitre contains 0.1 mg = 1 Each ampoule with 5 ml contains flumazenil.
Each ampoule with 10 ml contain micrograms flumazenil.
The other ingredients are disodi acid, sodium chloride, sodium hyd for injections.
What Flumazenil looks like and
Flumazenil is a clear and colourles and concentrate for solution for i
via wastewater or acist how to throw away se measures will help her information.
nil.
00 micrograms flumazenil. 0.5 mg = 500 micrograms s 1.0 mg = 1000 um edetate, glacial acetic roxide solution 4%, water contents of the pack s solution for injection nfusion in colourless glass ampoules.
Following packaging sizes are ava Carton boxes with 5 or 10 ampou solution.
Carton boxes with 5 or 10 ampou solution
Not all packaging sizes may be m
Marketing Authorisation Hold
Fresenius Kabi Limited
Cestrian Court, Eastgate Way, Ma Cheshire WA7 1NT
United Kingdom
This leaflet was last revised 05/20
ilable:
les containing 5 ml les containing 10 ml arked.
er and Manufacturer nor Park, Runcorn
16
The following information
Detailed storage condition When Flumazenil is to be u chloride 9 mg/ml (0.9% w/ (2.5% w/v) solution. Comp
This medicinal product mu
For further information on
is intended for healthcare professiona
s can be found in section 5. How to s sed in infusion, it must be diluted prior
- v) solution, glucose 50 mg/ml (5% w/v atibility between flumazenil and other
st not be mixed with other medicinal
dosage instructions please see sectio
ls only:
tore Flumazenil.
to infusion. Flumazenil should only be ) or sodium chloride 4.5 mg/ml (0.45% solutions for injection has not been es
products except for those mentioned
n 3 of the Package Information Leafle
diluted with sodium w/v) + glucose 25 mg/ml tablished.
in this section.
t.
